- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonfluent Aphasia, Progressive
Total 1894 results
-
Shinshu UniversityRecruitingOsteoarthritis of Multiple Joints | Progression of Rheumatoid ArthritisJapan
-
Eli Lilly and CompanyTerminatedAlzheimer's DiseaseUnited States, Australia, Canada, Japan
-
Cantonal Hospital of St. GallenCompletedChronic Obstructive Pulmonary Disease
-
Sheng LiuUnknownRecurrence | Overall Survival | Progression-Free-SurvivalChina
-
California Pacific Medical Center Research InstituteUniversity of Pittsburgh; Duke University; National Institute on Aging (NIA); University... and other collaboratorsRecruitingParkinson Disease | Osteoporosis | Parkinsonism | Multiple System Atrophy | Progressive Supranuclear Palsy | Parkinson's Disease and Parkinsonism | Dementia With Lewy Bodies | Atypical Parkinsonism | Vascular ParkinsonismUnited States
-
Institut National de la Santé Et de la Recherche...European UnionCompletedParkinson Disease | Dystonia | Multiple System Atrophy | Progressive Supranuclear Palsy | Huntington Disease | Diffuse Lewy Body DiseaseSlovenia, Germany, Croatia, France
-
Cellphire Therapeutics, Inc.Department of Health and Human ServicesTerminatedMyelodysplastic Syndromes | Myeloproliferative Disorders | Thrombocytopenia | Hematologic Malignancy | Bone Marrow Aplasia | Platelet RefractorinessUnited States, Israel, Norway
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedAtaxia | Multiple System Atrophy | Spinocerebellar Ataxias | Ataxia With Oculomotor Apraxia | CANVASItaly
-
Universitair Ziekenhuis BrusselRecruitingAlzheimer DiseaseBelgium
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
Kyorin UniversityJapan Clinical Oncology GroupRecruitingRecurrence | Glioblastoma | ProgressionJapan
-
Targovax OyCompletedAdvanced or Unresectable Melanoma Progressing After PD1 BlockadeUnited States, Norway
-
BiogenCompleted
-
BCDiabetes.CaUnknownDiabetes Mellitus, Type 2 | Psychological Distress
-
Karen-Lise Garm SpindlerRecruitingColorectal Cancer | Adjuvant Chemotherapy | Circulating Tumor DNA | Progression Free SurvivalDenmark
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Austria, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
Aveiro-Aradas Family Health UnitUnknown
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingAnemia, Diamond-BlackfanUnited States
-
Lawson Health Research InstituteRecruitingInterstitial PneumoniaCanada
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedCoronary Artery Disease | Progression of Atherosclerotic PlaqueTurkey
-
Qidong Gaitianli Medicines Co., LtdHuazhong University of Science and TechnologyTerminated
-
Arturo GarciaSyreon Corporation; Linde Health Care; Técnicas Avanzadas de Investigación en...CompletedDisease Progression | COPDSpain
-
Professor of Rheumatology, MD, DMSci, Kim Horslev-PetersenAbbott; Glostrup University Hospital, Copenhagen; Slagelse Hospital; King Christian...CompletedAutoimmune Diseases | Arthritis | Arthritis, Rheumatoid | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Connective Tissue DiseasesDenmark
-
McGill UniversityNovartisCompletedMultiple Sclerosis-Relapsing-RemittingCanada
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Saccadous, Inc.Barrow Neurological Institute; Dignity HealthCompletedParkinson Disease | Parkinsonian Disorders | Corticobasal Degeneration | Progressive Supranuclear Palsy | Huntington Disease | Essential Tremor | Parkinson's Disease and Parkinsonism | Vascular Parkinsonism | Parkinsonian Syndrome | Multiple System Atrophy, Parkinson VariantUnited States
-
Milton S. Hershey Medical CenterBioSensicsNot yet recruitingAmyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Progressive Muscular Atrophy
-
University of OklahomaTesaro, Inc.RecruitingRecurrent Cervix Cancer | Progressive Cervix CancerUnited States
-
PfizerNovartis; Keyrus BiopharmaCompletedPancreatic Neuroendocrine Tumor, Well Differentiated and ProgressiveFrance
-
Number 2 Children's Hospital, Ho Chi Minh CityRecruitingChild Development | Epilepsy; Seizure | Gene Abnormality | Early Onset DisorderVietnam
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
Novartis PharmaceuticalsRecruitingHormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationSpain, Italy, Austria
-
Memorial Sloan Kettering Cancer CenterBayer; National Comprehensive Cancer NetworkActive, not recruitingHepatocellular CarcinomaUnited States
-
Alnylam PharmaceuticalsCompletedAmyloidosis, Familial | Transthyretin AmyloidosisFrance, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
-
Chinese PLA General HospitalCompletedCost | Overall Survival | Progression-free Survival
-
Wake Forest University Health SciencesAgency for Healthcare Research and Quality (AHRQ)Completed
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveUnited States
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Overall Survival | Progression-free Survival | Clinical Benefit RateChina
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Tufts...CompletedDietary Modification | Kidney Diseases, ChronicUnited States
-
Ankara Training and Research HospitalCompletedDisease Progression | Bladder Cancer | Recurrent Bladder Cancer
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloUnknownApraxia | Rolandic EpilepsyBrazil
-
PfizerRecruitingTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM)United States
-
Zhujiang HospitalRecruitingHigh Grade Glioma | Radiation Toxicity | Overall Survival | Progression-free Survival | MRI Simulated PositioningChina
-
University of South FloridaRecruiting
-
Prof. Dr. Jörg LeuppiKantonsspital Baselland Bruderholz; Institut für Hausarztmedizin BaselRecruitingPulmonary Disease, Chronic Obstructive | Disease Exacerbation | Adverse Effect of Glucocorticoids and Synthetic AnaloguesSwitzerland
-
University of Southern CaliforniaCompletedPrevention of Subclinical Atherosclerosis Progression | Prevention of Cognitive DeclineUnited States
-
Winthrop University HospitalCompletedEnd Stage Renal Disease | Chronic Kidney DiseaseUnited States
-
China-Japan Friendship HospitalUnknownCOPD ExacerbationChina